Relapse‐related molecular signature in early‐stage lung adenocarcinomas based on base excision repair, stimulator of interferon genes pathway and tumor‐infiltrating lymphocytes

Approximately 30% of patients with early‐stage non–small cell lung cancer (NSCLC) relapse within 5 years after surgery. Therefore, it is necessary to identify a robust and reliable prognostic signature for early‐stage NSCLC. Immunohistochemistry data from 147 patients with stage I lung adenocarcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bo, Rao, Wen, Luo, Hao, Zhang, Liang, Wang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Basic and Clinical Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541020/
https://www.ncbi.nlm.nih.gov/pubmed/32654272
http://dx.doi.org/10.1111/cas.14570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541020/
https://www.ncbi.nlm.nih.gov/pubmed/32654272
http://dx.doi.org/10.1111/cas.14570

Ejemplares similares